Completed
Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors
NCT00777699
- Conditions
- Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Investigational Site Number 168983 Philadelphia, Pennsylvania, United States